Contract DOCSB134110SU1042
Solomon Park Research Laboratories, Inc · Department Of Commerce · September 18, 2010
Solomon Park Research Laboratories, Inc was awarded a federal contract by Department Of Commerce (National Institute Of Standards And Technology) on September 18, 2010 for $61,000 of work in biological product (except diagnostic) manufacturing. Performance is in Kirkland, WA. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 23, 2016.
Contract details
- PIID
- DOCSB134110SU1042
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Kirkland, WA
- First action
- September 18, 2010
- Latest action
- February 23, 2016
Description
RECORD CORRECTED ON 4/7/17 TO REFLECT CONTRACT CLOSEOUT
Modification timeline
-
February 23, 2016Mod 3$0
-
April 14, 2015Mod 2HUMAN SERUM$-118
-
September 24, 2011Mod P001VITAMIN D SRM VIALS$1.5K
-
September 18, 2010Base awardSRM- VITAMIN D IS HUMAN SERUM$59.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Illumina, Inc. | Department Of Commerce | September 19, 2025 | $46.6K |
| American Type Culture Collection | Department Of Commerce | September 19, 2025 | $338.2K |
| Solomon Park Research Laboratories, Inc | Department Of Commerce | September 3, 2025 | $273.7K |
| Eurofins Lancaster Laboratories Llc | Department Of Commerce | June 28, 2024 | $349.6K |
| Mckesson Medical-Surgical Government Solutions Llc | Department Of Commerce | September 15, 2021 | $4.1K |
| Promega Corporation | Department Of Commerce | August 12, 2011 | $15.9K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract DOCSB134110SU1042?
Contract DOCSB134110SU1042 is a federal contract awarded to Solomon Park Research Laboratories, Inc by Department Of Commerce on September 18, 2010 for $61,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 3 times since the base award.
Who won contract DOCSB134110SU1042?
Solomon Park Research Laboratories, Inc won contract DOCSB134110SU1042 from Department Of Commerce.
How much is contract DOCSB134110SU1042 worth?
Contract DOCSB134110SU1042 has obligated $61,000 to date.